Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Digital polymerase chain reaction (dPCR) technology is an advanced version of the polymerase chain reaction (PCR) technology that enables users to amplify and directly quantify nucleic acids, such as DNA, RNA, cDNA, and methylated DNA with a high level of precision. The technique allows users to statistically analyze PCR products by converting exponential, analog signals obtained from conventional PCR technology to linear and digital signals.
One of the primary drivers for this market is the rise in the focus on disease diagnosis and drug discovery and development. This increase in focus on medical research and drug discovery and development of several diseases is mainly driven by pharmaceutical and biotechnology companies as well as by research institutes. Also, it has been observed that governments of many developed and developing countries have been supporting research for new drug discovery and development. dPCR technology plays a vital role in drug discovery and development and for gene expression profiling, nucleic acid sequencing, and pharmacogenomics. Consequently, the major pharmaceutical and biotechnology companies will increase their adoption of dPCR technology due to high specificity, high accuracy, and productive results in developing new drug candidates. Such factors are expected to propel growth in the global dPCR market during the forecast period.
The global dPCR market is largely fragmented with the presence of many international and regional players present across the globe. The demand for dPCR solutions will be high in emerging countries, especially the BRIC countries (Brazil, Russia, India, China, and South Africa), due to an increase in their investments in drug research activities in various fields, including diagnosis of cancer. This rise is expected to intensify the competition among vendors in the next few years.
In 2019, the market size of dPCR is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for dPCR.
This report studies the global market size of dPCR, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the dPCR production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Bio-Rad Laboratories
Fluidigm
RainDance Technologies
Thermo Fisher Scientific
Becton
Dickinson and Company
Exiqon
Formulatrix
Promega Corporation
Sigma-Aldrich
Stilla Technologies
Market Segment by Product Type
Consumables
Instruments
Market Segment by Application
Research Laboratories and Academic Institutes
Pharma and Biotech Companies
Hospitals and Diagnostic Centers
Clinical Research Organizations
Forensic Laboratories
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the dPCR status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key dPCR manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of dPCR are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
One of the primary drivers for this market is the rise in the focus on disease diagnosis and drug discovery and development. This increase in focus on medical research and drug discovery and development of several diseases is mainly driven by pharmaceutical and biotechnology companies as well as by research institutes. Also, it has been observed that governments of many developed and developing countries have been supporting research for new drug discovery and development. dPCR technology plays a vital role in drug discovery and development and for gene expression profiling, nucleic acid sequencing, and pharmacogenomics. Consequently, the major pharmaceutical and biotechnology companies will increase their adoption of dPCR technology due to high specificity, high accuracy, and productive results in developing new drug candidates. Such factors are expected to propel growth in the global dPCR market during the forecast period.
The global dPCR market is largely fragmented with the presence of many international and regional players present across the globe. The demand for dPCR solutions will be high in emerging countries, especially the BRIC countries (Brazil, Russia, India, China, and South Africa), due to an increase in their investments in drug research activities in various fields, including diagnosis of cancer. This rise is expected to intensify the competition among vendors in the next few years.
In 2019, the market size of dPCR is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for dPCR.
This report studies the global market size of dPCR, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the dPCR production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Bio-Rad Laboratories
Fluidigm
RainDance Technologies
Thermo Fisher Scientific
Becton
Dickinson and Company
Exiqon
Formulatrix
Promega Corporation
Sigma-Aldrich
Stilla Technologies
Market Segment by Product Type
Consumables
Instruments
Market Segment by Application
Research Laboratories and Academic Institutes
Pharma and Biotech Companies
Hospitals and Diagnostic Centers
Clinical Research Organizations
Forensic Laboratories
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the dPCR status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key dPCR manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of dPCR are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
